Azadeh Azizian

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Impact of superior mesenteric artery (SMA) adherent tissue in the context of pancreatic head resections- an observational study.

Impact of superior mesenteric artery (SMA) adherent tissue in the context of pancreatic head resections- an observational study.

Journal: BMC cancer

Published: January 05, 2026

Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial.

Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial.

Journal: Scientific reports

Published: October 09, 2024

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

Journal: bioRxiv : the preprint server for biology

Published: June 21, 2024

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

Journal: Carcinogenesis

Published: March 14, 2024

Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver Resection.

Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver Resection.

Journal: Biomedicines

Published: December 13, 2023

Short- and Long-Term Outcomes of Patients with Postoperative Arrhythmia after Liver Surgery.

Short- and Long-Term Outcomes of Patients with Postoperative Arrhythmia after Liver Surgery.

Journal: Biomedicines

Published: December 09, 2023

LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.

LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.

Journal: Carcinogenesis

Published: November 14, 2023

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.

Journal: International journal of cancer

Published: September 25, 2023

Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection.

Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection.

Journal: Biomedicines

Published: August 20, 2023

MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways.

MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways.

Journal: Carcinogenesis

Published: August 17, 2023

SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer.

SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer.

Journal: Cell reports

Published: April 19, 2023

Whole 16S rRNA sequencing of the oral microbiome predicts postoperative pancreatic fistula: prospective observational cohort study.

Whole 16S rRNA sequencing of the oral microbiome predicts postoperative pancreatic fistula: prospective observational cohort study.

Journal: The British journal of surgery

Published: January 12, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026